Urs P. Steinbrecher

11.0k citations

101 papers · 8.1k indexed · 3 hit papers · h-index 43

Biochemistry top 0.05%
Immunology top 1%
Molecular Biology top 5%
Surgery top 1%
Epidemiology top 1%

Co-authors: Joseph L. Witztum Marilee Lougheed Daniel Steinberg Srinivasan Parthasarathy David S. Leake Antonio Gómez‐Muñoz Jennifer Y. Kong Linda K. Curtiss
Topics: Antioxidant Activity and Oxidative Stress (25 papers)Atherosclerosis and Cardiovascular Diseases (17 papers)Sphingolipid Metabolism and Signaling (15 papers)
Cited by: Biochemistry Hepatology Immunology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Circulation
Partner nations: Canada United States Spain

In The Last Decade

Urs P. Steinbrecher

101 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

1984 1.4k citations Urs P. Steinbrecher et al. profile →
Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products.

1987 546 citations Urs P. Steinbrecher Journal of Biological Chemistry profile →
Role of oxidatively modified LDL in atherosclerosis

1990 521 citations Urs P. Steinbrecher, Marilee Lougheed et al. Free Radical Biology and Medicine profile →

Peers

Countries citing papers authored by Urs P. Steinbrecher

Since Specialization

Citations

This map shows the geographic impact of Urs P. Steinbrecher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urs P. Steinbrecher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urs P. Steinbrecher more than expected).

Fields of papers citing papers by Urs P. Steinbrecher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urs P. Steinbrecher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urs P. Steinbrecher. The network helps show where Urs P. Steinbrecher may publish in the future.

Co-authorship network of co-authors of Urs P. Steinbrecher

This figure shows the co-authorship network connecting the top 25 collaborators of Urs P. Steinbrecher. A scholar is included among the top collaborators of Urs P. Steinbrecher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urs P. Steinbrecher. Urs P. Steinbrecher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis 2012 ·Case Reports in Gastroenterology ·(unknown),Janakie Singham,Robert A. Hegele,Maziar Riazy,Matti A. Hiob,Gordon A. Francis,Urs P. Steinbrecher	8
2	Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival 2009 ·Journal of Lipid Research ·(unknown),Maziar Riazy,(unknown),Jiazhen Dai,Vincent Duronio,Urs P. Steinbrecher	6
3	LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma 2009 ·Journal of Lipid Research ·David F. Schaeffer,Maziar Riazy,Ken Kuljit S. Parhar,(unknown),Vincent Duronio,Tatsuya Sawamura,Urs P. Steinbrecher	58
4	Pertussis toxin promotes macrophage survival through inhibition of acid sphingomyelinase and activation of the phosphoinositide 3-kinase/protein kinase B pathway 2007 ·Cellular Signalling ·Shaomeng Wang,Ken Kuljit S. Parhar,(unknown),(unknown),Patricia Gangoiti,Jennifer Y. Kong,Monika González-Lopez,Baljinder Salh,Vincent Duronio,Urs P. Steinbrecher	16
5	Spatulated end‐to‐end bile duct reconstruction in orthotopic liver transplantation 2007 ·Clinical Transplantation ·Andrzej K. Buczkowski,David F. Schaeffer,Peter T. W. Kim,Stephen Ho,Eric M. Yoshida,Urs P. Steinbrecher,Siegfried R. Erb,Stephen W. Chung,Charles H. Scudamore	8
6	Utilization of a Liver Allograft from a Hepatitis B Surface Antigen Positive Donor 2006 ·Transplantation ·(unknown),P. Richard Harrigan,Christopher H. Sherlock,Urs P. Steinbrecher,Siegfried R. Erb,Theresa Mo,Stephen W. Chung,(unknown),(unknown),Charles H. Scudamore,Eric M. Yoshida	15
7	Subcutaneous administration of hepatitis B immune globulin in combination with lamivudine following orthotopic liver transplantation: effective prophylaxis against recurrence 2006 ·Clinical Transplantation ·James J. Powell,(unknown),Nilufar Partovi,Siegfried R. Erb,Charles H. Scudamore,Urs P. Steinbrecher,(unknown),Stephen W. Chung,Eric M. Yoshida	12
8	Transplant immunosuppressive agents in non‐transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus 2005 ·Liver International ·(unknown),Alnoor Ramji,Vincent G. Bain,Mang Ma,Paul J. Marotta,Cameron N. Ghent,Leslie Lilly,E. Jenny Heathcote,Marc Deschênes,Samuel S. Lee,Urs P. Steinbrecher,Eric M. Yoshida	87
9	Hepatic abscesses after liver transplantation secondary to traumatic intrahepatic bile duct injuries in a cadaveric allograft donor 2004 ·Transplant International ·(unknown),Eric M. Yoshida,Anthony G. Ryan,Stephen W. Chung,(unknown),Stephen Ho,S. Erb,Urs P. Steinbrecher,Charles H. Scudamore	7
10	Acid sphingomyelinase in macrophage apoptosis 2004 ·Current Opinion in Lipidology ·Urs P. Steinbrecher,Antonio Gómez‐Muñoz,Vincent Duronio	30
11	Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages 2004 ·Journal of Lipid Research ·Antonio Gómez‐Muñoz,Jennifer Y. Kong,B Salh,Urs P. Steinbrecher	175
12	Sphingosine‐1‐phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages 2003 ·FEBS Letters ·Antonio Gómez‐Muñoz,Jennifer Y. Kong,B Salh,Urs P. Steinbrecher	71
13	The p38 mitogen‐activated protein kinase regulates interleukin‐1β‐induced IL‐8 expression via an effect on the IL‐8 promoter in intestinal epithelial cells 2003 ·Immunology ·Ken Kuljit S. Parhar,Andrew M. Ray,Urs P. Steinbrecher,Colleen C. Nelson,Baljinder Salh	59
14	5-Aminosalicylate stimulates phospholipase D activity in macrophages 2001 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Antonio Gómez‐Muñoz,Lewis Yarlupurka O'Brien,Baljinder Salh,Urs P. Steinbrecher	11
15	A Modification of Apolipoprotein B Accounts for Most of the Induction of Macrophage Growth by Oxidized Low Density Lipoprotein 1999 ·Journal of Biological Chemistry ·(unknown),Marilee Lougheed,Antonio Gómez‐Muñoz,Urs P. Steinbrecher	42
16	High Affinity Saturable Uptake of Oxidized Low Density Lipoprotein by Macrophages from Mice Lacking the Scavenger Receptor Class A Type I/II 1997 ·Journal of Biological Chemistry ·Marilee Lougheed,(unknown),Wenhua Ling,Hiroshi Suzuki,Tatsuhiko Kodama,Urs P. Steinbrecher	108
17	ALTERATION OF THE DISMAL NATURAL HISTORY OF FIBROSING CHOLESTATIC HEPATITIS SECONDARY TO HEPATITIS B VIRUS WITH THE USE OF LAMIVUDINE 1997 ·Transplantation ·(unknown),Eric M. Yoshida,Jennifer Davis,Robert K. Vartanian,Frank Anderson,Urs P. Steinbrecher	43
18	Effects of oxidized low density lipoprotein on endothelin secretion by cultured endothelial cells and macrophages 1996 ·Atherosclerosis ·Yi He,(unknown),Urs P. Steinbrecher	27
19	Role of oxidatively modified LDL in atherosclerosisbreakdown → 1990 ·Free Radical Biology and Medicine ·Urs P. Steinbrecher,(unknown),Marilee Lougheed	521
20	Heparin-associated thrombocytopenia: low frequency in 104 patients treated with heparin of intestinal mucosal origin. 1979 ·PubMed ·(unknown),(unknown),Urs P. Steinbrecher	41

About Urs P. Steinbrecher

Urs P. Steinbrecher is a scholar working on Biochemistry, Hepatology and Transplantation, having authored 101 papers that have together received 8.1k indexed citations. Recurring topics across this work include Antioxidant Activity and Oxidative Stress (25 papers), Atherosclerosis and Cardiovascular Diseases (17 papers) and Sphingolipid Metabolism and Signaling (15 papers). The work is most often cited by research in Biochemistry (2.5k citations), Hepatology (1.1k citations) and Immunology (2.4k citations). Urs P. Steinbrecher has collaborated with scholars based in Canada, United States and Spain. Frequent co-authors include Joseph L. Witztum, Marilee Lougheed, Daniel Steinberg, Srinivasan Parthasarathy, David S. Leake, Antonio Gómez‐Muñoz, Jennifer Y. Kong, Linda K. Curtiss, Eric M. Yoshida and P. Haydn Pritchard. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact